Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Andrew Epstein

Clinical Cardiac Electrophysiology Philadelphia, PA Medical Doctor

NPI 1649214800 CMS profile 301575

3400 Civic Center Blvd East Pavilion, 2Nd Floor, Philadelphia, PA 19104

Open in the dashboard

General payments

$108,585

143 records reported · program years 2019–2025

Research payments

$4,428

Paid to them · 5 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Andrew Epstein of Philadelphia, PA is reported in the CMS Open Payments database as having received $108,585 across 143 general payments and $4,428 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 89th percentile of Clinical Cardiac Electrophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $8,602 8
2024 General $229 3
2023 General $8,289 8
2022 General $13,415 17
2021 General $8,400 12
2020 General $17,859 27
2020 Research $385 1
2019 General $51,791 68
2019 Research $4,043 4

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Andrew Epstein
  • Clinical Cardiac Electrophysiology median
  • Middle half of Clinical Cardiac Electrophysiology
  • National median

In program year 2025, general payments to Andrew Epstein were reported at $8,602. Among 3,064 Clinical Cardiac Electrophysiology profiles paid that year, the median was $2,462 and the middle half received between $733 and $7,710.

Show as a table
Year Andrew Epstein Clinical Cardiac Electrophysiology median Middle half National median
2019 $51,791 $2,361 $585–$8,260 $163
2020 $17,859 $993 $247–$4,351 $114
2021 $8,400 $1,185 $326–$4,739 $132
2022 $13,415 $2,073 $554–$6,789 $149
2023 $8,289 $2,568 $759–$8,159 $160
2024 $229 $2,557 $703–$7,403 $164
2025 $8,602 $2,462 $733–$7,710 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Abbott Laboratories $52,188 77 payments
  2. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $25,609 12 payments
  3. Boston Scientific Corporation $23,169 28 payments
  4. Medtronic Vascular, Inc. $6,535 13 payments
  5. AltaThera Pharmaceuticals LLC $500 1 payment
  6. Biotronik Inc. $262 4 payments
  7. Medtronic, Inc. $111 3 payments
  8. Biosense Webster, Inc. $74 1 payment
  9. Merck Sharp & Dohme Corporation $64 1 payment
  10. Akcea Therapeutics, Inc. $36 1 payment
  11. Other $38 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $87,042 76 payments
  2. Honoraria $8,000 2 payments
  3. Travel and Lodging $5,317 16 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $5,000 1 payment
  5. Food and Beverage $3,227 48 payments
Products named General payments · program years 2019–2025
  1. LifeVest $25,609 12 payments
  2. CLINICAL TRIAL PRODUCT $21,722 18 payments
  3. ENSITE PRECISION $12,431 13 payments
  4. Optisure Defibrillation ICD Lead $11,250 13 payments
  5. HeartMate $7,722 5 payments
  6. EnSite Precision Cardiac Mapping System $7,500 10 payments
  7. Quartet CRT Lead $3,600 5 payments
  8. Ensite Cardiac Mapping System $2,557 13 payments
  9. Merlin Connectivity and Remote $2,500 6 payments
  10. Durata Defibrillation ICD Lead $1,575 1 payment
  11. Other $4,599 33 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Medtronic Vascular, Inc. $4,428 5 payments

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

11

Median for Clinical Cardiac Electrophysiology: 1,090

Drug cost

$0

Median for Clinical Cardiac Electrophysiology: $354,841

Branded share of claims

0%

Median for Clinical Cardiac Electrophysiology: 38.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Lisinopril Generic 11 $0

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,573 Part D prescribers listed as Clinical Cardiac Electrophysiology; they describe a distribution and say nothing about conduct.

Records

148 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Cardiac Electrophysiology in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record